Sara Tolaney has Medical Oncology as her primary medical specialty. Their primary office is: 450 Brookline Ave in Boston, Massachusetts.
They're a part of the: Dana-farber Cancer Institute, Inc. medical group which has around 542 members. You can call their office at - to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of California, San Francisco School Of Medicine and graduated in 2002 (around 22 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.
Sara Tolaney
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, Massachusetts 02215
-
Enter a starting address:
Additional Medical Specialties Include:
HEMATOLOGY, INTERNAL MEDICINE
Medical School: University Of California, San Francisco School Of Medicine
Graduation Year: 2002
The Primary Medical Specialty for Sara Tolaney is listed as: Medical Oncology
Approximate Years of Experience: 22
PAC (PECOS ID)#: 2567536154
NPI #: 1962487330
NPI Created On: 12/08/2005
NPI Last Updated Listed as: 04/23/2018
Primary Taxonomy Code: 207R00000X
License Number:
223936
Listed Gender: Female
Forms of insurance accepted by include, but are not limited to:
They are listed as accepting new patients.
Languages spoken by staff include: English.
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $18,200
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Context of payment:: SERVICES TO SUPPORT RESEARCH RELATED ACTIVITIES
Record ID:: 818698387
Being Disputed:: No
Product Related: Yes
Payments Total: $1,750
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Record ID:: 818751681
Being Disputed:: No
Product Related: No
Payments Total: $3,500
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Record ID:: 818679565
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: VERZENIO
Open Associated Drug #1: 0002-6216-54
Payments Total: $1,400
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Record ID:: 818723723
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: VERZENIO
Open Associated Drug #1: 0002-6216-54
Payments Total: $1,610
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 832194103
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: TUKYSA
Open Associated Drug #1: 51144-001-60
Payments Total: $3,850
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 832194143
Being Disputed:: No
Product Related: No
Payments Total: $1,035
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 832194193
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: TUKYSA
Open Associated Drug #1: 51144-001-60
Payments Total: $1,980
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Ownership Interest: Yes
Third party is a Charity:: No
Record ID:: 835974063
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: BioOncology
Name of Drug #1: TECENTRIQ
Open Associated Drug #1: 50242-917-01
Payments Total: $660
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Ownership Interest: Yes
Third party is a Charity:: No
Record ID:: 835974065
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Payments Total: $990
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Ownership Interest: Yes
Third party is a Charity:: No
Record ID:: 835974059
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: BioOncology
Name of Drug #1: Phesgo
Open Associated Drug #1: 50242-245-01
450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.
75 Francis St
Boston, MA
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.
20 Prospect St
Milford Ma 01757-3042
Dana-farber Cancer Institute, Inc.
Medical Oncology
450 Brookline Ave
Boston Ma 02215-5418
Dana-farber Cancer Institute, Inc.
Medical Oncology
75 Francis St
Boston Ma 02115-6110
Dana-farber Cancer Institute, Inc.
Internal Medicine
450 Brookline Ave
Boston Ma 02215-5418
Dana-farber Cancer Institute, Inc.
Internal Medicine
22 Patriot Pl
Foxborough Ma 02035-1375
Dana-farber Cancer Institute, Inc.
Medical Oncology
75 Francis St
Boston Ma 02115-6110
Dana-farber Cancer Institute, Inc.
Medical Oncology
View all 542 members of Dana-farber Cancer Institute, Inc. medical group